This site is intended only for healthcare professionals residing in Singapore




Sign InLog Out Our medicinesTherapy areasExplore contentExplore contentEventsMaterialsVideosLet’s connectLet's ConnectContact usPfizer medical information



Non-valvular atrial fibrillation (NVAF)

Non-valvular atrial fibrillation (NVAF) is a common heart arrhythmia, affecting one in 20 people over the age of 65 and one in ten over the age of 751

Explore the latest best practices and resources to help healthcare professionals in the management of NVAF.

Learn more
Venous thromboembolism (VTE)

Venous thromboembolism (VTE) is a condition in which a blood clot forms2

Explore the latest best practices and resources to help healthcare professionals in the management of VTE.

Learn more
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Improve your understanding of the causes, signs, and symptoms, as well as diagnostic tools and treatment strategies, associated with ATTR-CM.

Learn more
Hankey GJ. Non-valvular atrial fibrillation and stroke prevention. Medical Journal of Australia. 2001;174:234–239 Available at: Accessed April 2022Blann A D et al. BMJ 2006;332:215-9 doi:10.1136/bmj.332.7535.215
PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign inRegisterAccountSign Out

The information provided in this site is intended only for Healthcare Professionals in Singapore. The products discussed herein may have different product labelling in different countries. Pfizer Pte Ltd, Singapore is a subsidiary of Pfizer Inc, a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.

Copyright © 2023 Pfizer Limited. All rights reserved.

You are now leaving the website
You are now leaving a Pfizer-operated website. Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.